Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients
AUTOR(ES)
Ferreira, Renata Cristina, Ianni, Barbara M, Abel, Lucia CJ, Buck, Paula, Mady, Charles, Kalil, Jorge, Cunha-Neto, Edecio
FONTE
Memórias do Instituto Oswaldo Cruz
DATA DE PUBLICAÇÃO
2003-04
RESUMO
We compared plasma tumor necrosis factor-alpha (TNF-alpha) levels among asymptomatic/"indeterminate" Chagas disease patients (ASY) and patients across the clinical spectrum of chronic Chagas disease cardiomyopathy (CCC). Idiopathic dilated cardiomyopathy (DCM) patients and normal controls (NC) were included as controls. ASY Chagas disease patients had significantly higher plasma TNF-alpha levels than NC. TNF-alpha levels among severe CCC patients with significant left ventricular (LV) dysfunction were similar to those of DCM patients, showing average 2-fold higher levels than CCC patients without LV dysfunction and ASY patients, and 8-fold higher levels than NC. In Chagas disease, chronic TNF-a production prior to heart failure may play a role in CCC progression.
Documentos Relacionados
- Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
- Oxpentifylline, tumour necrosis factor-alpha and Crohn's disease.
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Increased production of tumor necrosis factor-alpha in whole blood cultures from children with primary malnutrition
- Tumor necrosis factor-alpha inhibits expression of pulmonary surfactant protein.